Financial reports
10-Q
2017 Q2
Quarterly report
9 Aug 17
10-Q
2017 Q1
Quarterly report
10 May 17
10-K/A
2016 FY
Annual report (amended)
10 May 17
10-K
2016 FY
Annual report
16 Mar 17
10-Q
2016 Q3
Quarterly report
9 Nov 16
10-Q
2016 Q2
Quarterly report
5 Aug 16
10-Q
2016 Q1
Quarterly report
10 May 16
10-K
2015 FY
Annual report
30 Mar 16
NT 10-K
Notice of late annual filing
11 Mar 16
10-Q
2015 Q3
Quarterly report
9 Nov 15
Current reports
8-K
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR
31 Aug 17
8-K
Submission of Matters to a Vote of Security Holders
18 Aug 17
8-K
Other Events
10 Jul 17
8-K
AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR’s Proposed Acquisition of AMRI
29 Jun 17
8-K
AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash
6 Jun 17
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 17
8-K
AMRI Announces First Quarter 2017 Results
10 May 17
8-K
AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook
21 Feb 17
8-K
Other Events
22 Dec 16
8-K
AMRI Announces Third Quarter 2016 Results
8 Nov 16
Registration and prospectus
15-12B
Securities registration termination
31 Aug 17
25-NSE
Exchange delisting
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Aug 17
Proxies
DEFA14A
Additional proxy soliciting materials
4 Aug 17
DEFM14A
Proxy related to merger
14 Jul 17
DEFA14A
Additional proxy soliciting materials
10 Jul 17
PREM14A
Preliminary proxy related to merger
3 Jul 17
DEFA14A
Additional proxy soliciting materials
29 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
Other
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
25 Apr 17
CORRESP
Correspondence with SEC
21 Apr 17
CORRESP
Correspondence with SEC
30 Mar 17
Ownership
SC 13G/A
Albany Molecular Research Inc
14 Feb 18
SC 13G/A
Albany Molecular Research Inc
13 Feb 18
4
MILTON BOYER
5 Sep 17
4
KENNETH PAUL HAGEN
5 Sep 17
4
Steven R Hagen
5 Sep 17
4
LORI M. HENDERSON
5 Sep 17
4
ANTHONY J MADDALUNA
5 Sep 17
4
KEVIN OCONNOR
5 Sep 17
4
William S Marth
5 Sep 17
4
AMBRA THOMAS E D
5 Sep 17